Sodium risedronate
Sponsors
Takeda
Conditions
Osseous Paget's DiseaseOsteoporosis
Unknown Phase
Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)
CompletedNCT02089997
Start: 2013-05-27End: 2016-04-30Updated: 2018-10-19
Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -
CompletedNCT02106455
Start: 2008-08-01End: 2017-10-24Updated: 2019-06-03
36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets
CompletedNCT02106442
Start: 2013-05-13End: 2018-04-30Updated: 2019-07-30